Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SANTAX MEDICO A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   1.3% 0.8% 0.9% 1.2% 1.4% 0.8% 8.8% 8.6%   Credit score (0-100)   81 92 87 81 77 92 28 29   Credit rating   A AA A A A AA BB BB   Credit limit (kDKK)   323.5 2,193.5 1,503.7 374.8 200.7 1,680.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   32,027 29,529 33,478 29,082 33,254 30,368 0.0 0.0   EBITDA   9,177 8,219 10,758 5,997 8,964 6,293 0.0 0.0   EBIT   7,498 6,497 9,054 4,341 7,553 4,765 0.0 0.0   Pre-tax profit (PTP)   7,387.5 6,376.0 9,060.8 4,376.2 7,396.6 4,661.9 0.0 0.0   Net earnings   5,753.5 4,968.0 7,064.4 3,501.7 5,784.8 3,626.1 0.0 0.0   Pre-tax profit without non-rec. items   7,388 6,376 9,061 4,376 7,397 4,662 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   6,905 6,636 6,847 4,834 5,336 6,121 0.0 0.0   Shareholders equity total   15,438 15,406 11,070 9,572 11,857 10,483 4,483 4,483   Interest-bearing liabilities   1,263 0.0 0.0 0.0 3,748 0.0 0.0 0.0   Balance sheet total (assets)   60,522 47,815 38,613 37,339 50,028 31,923 4,483 4,483   Net Debt   1,104 -3,765 -1,469 -2,027 3,599 -2,637 -4,483 -4,483     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   32,027 29,529 33,478 29,082 33,254 30,368 0.0 0.0   Gross profit growth   3.5% -7.8% 13.4% -13.1% 14.3% -8.7% -100.0% 0.0%   Employees   32 33 31 31 31 31 0 0   Employee growth %   -8.6% 3.1% -6.1% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   60,522 47,815 38,613 37,339 50,028 31,923 4,483 4,483   Balance sheet change%   42.0% -21.0% -19.2% -3.3% 34.0% -36.2% -86.0% 0.0%   Added value   9,177.1 8,218.7 10,758.2 5,997.2 9,210.0 6,293.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -859 -1,991 -1,493 -3,669 -909 -744 -6,121 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   23.4% 22.0% 27.0% 14.9% 22.7% 15.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.5% 12.0% 21.1% 11.7% 17.5% 11.7% 0.0% 0.0%   ROI %   36.8% 31.6% 48.7% 27.2% 44.6% 29.4% 0.0% 0.0%   ROE %   40.9% 32.2% 53.4% 33.9% 54.0% 32.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   35.2% 38.8% 32.9% 31.8% 27.0% 42.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   12.0% -45.8% -13.7% -33.8% 40.2% -41.9% 0.0% 0.0%   Gearing %   8.2% 0.0% 0.0% 0.0% 31.6% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.2% 20.6% 0.0% 0.0% 13.2% 7.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.6 1.6 1.2 1.5 1.3 1.6 0.0 0.0   Current Ratio   1.3 1.5 1.5 1.4 1.4 1.6 0.0 0.0   Cash and cash equivalent   159.2 3,764.9 1,469.2 2,026.7 148.6 2,636.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   12,319.7 12,858.0 9,908.7 9,559.6 11,553.2 8,881.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   287 249 347 193 297 203 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   287 249 347 193 289 203 0 0   EBIT / employee   234 197 292 140 244 154 0 0   Net earnings / employee   180 151 228 113 187 117 0 0